The University of Alabama at Birmingham has been identified by Emerging Therapy Solutions (ETS) as a Program of Experience for Chimeric antigen receptor T cell therapy.

CAR-T therapy is a path for T cells to fight cancer by changing them in the lab so they can find and destroy cancer cells. It is becoming an essential pillar of cancer care.

"The UAB-BMT and Cell Therapy Program is the only state-of-the-art program in Alabama to offer CAR-T therapy for patients with some cancers," said Amitkumar Mehta, MD, associate scientist in the O'Neal Comprehensive Cancer Center. "I am very proud to be part of the program."